论文部分内容阅读
目的:探讨采用不同抗菌药物治疗ICU泛耐药鲍曼不动杆菌感染的治疗疗效。方法:选取2014年7月-2015年6月该院92例泛耐药鲍曼不动杆菌感染患者,根据不同治疗方案将其分为A组与B组,两组各为46例。B组采用头孢哌酮舒巴坦联合米诺环素进行治疗,A组则采用多黏菌素进行干预治疗,并分析对比两组治疗疗效。结果:通过采用不同治疗方案,A组治疗疗效更优,两组对比具有较大差异性(P<0.05)。结论:采用多黏菌素干预治疗泛耐药鲍曼不动杆菌感染,可缓解不良症状,提升治疗疗效,减轻损伤,具备临床意义与价值。
Objective: To investigate the curative effect of different antimicrobial agents for the treatment of Acinetobacter baumannii infection in ICU. Methods: From July 2014 to June 2015, 92 cases of pan-drug-resistant Acinetobacter baumannii infection in this hospital were divided into group A and group B according to different treatment plans, 46 cases in each group. Group B was treated with cefoperazone and sulbactam combined with minocycline, group A was treated with polymyxin, and compared the therapeutic effect of the two groups. Results: The treatment effect of group A was better than that of group A, with significant difference between the two groups (P <0.05). Conclusion: The use of polymyxin to treat pan-resistant Acinetobacter baumannii infection can alleviate the adverse symptoms, improve the curative effect and reduce the injury, which has clinical significance and value.